MedPath
NMPA Approval

Lamotrigine Dispersible Tablets

国药准字H20244887

September 10, 2024

Drug Information

拉莫三嗪分散片

片剂

25mg

化学药品

September 10, 2024

Company Information

Applicant Company

江西省抚州市东乡区大富工业园区

Manufacturing Company

江西省抚州市东乡区大富工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.